End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
904.9 USD | 0.00% | 0.00% | 0.00% |
Jul. 08 | Health Care Flat Amid Deal Activity -- Health Care Roundup | DJ |
Jul. 08 | S&P 500, Nasdaq Extend Record Closing Runs | MT |
Financials (USD)
Sales 2024 * | 42.97B | Sales 2025 * | 52.69B | Capitalization | 827B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B | Net income 2025 * | 16.63B | EV / Sales 2024 * | 19.7 x |
Net Debt 2024 * | 19.94B | Net Debt 2025 * | 16.06B | EV / Sales 2025 * | 16 x |
P/E ratio 2024 * |
68.6
x | P/E ratio 2025 * |
49.1
x | Employees | 43,000 |
Yield 2024 * |
0.57% | Yield 2025 * |
0.65% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | +1.69% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Ruth Gimeno
PSD | President | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 64 | 04-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.18% | 353B | |
+15.37% | 320B | |
+7.45% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.14% | 167B | |
-2.99% | 159B | |
+2.61% | 123B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock